Drug Trial Radar · NCT05928169
Determinants of Chronic Inflammatory Skin Disease Trajectories
Last checked: Nov 20, 2026Latest source record: Aug 28, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
1,000
Planned (sponsor's estimate)
Start
May 1, 2023
Primary completion
Apr 30, 2032
Study completion Dec 31, 2032
Sponsor
- Lead sponsor
- University Hospital Schleswig-HolsteinAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Jul 3, 2023
Design
- Study type
- Observational
- FDA-regulated drug
- No
- Who can join
- All sexes, from 0 years, up to 80 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
Although it is well known that the clinical expression and course of chronic inflammatory skin diseases are highly variable, there are insufficient epidemiological data on this, and the factors that determine the manifestation, clinical features and course are also largely unknown. There are currently no reliable markers that could predict or delineate patient subgroups to support patient management. The aim of this project is to identify clinical and molecular factors that correlate with disease, disease subtypes and progression through in-depth long-term clinical characterization of patients with chronic inflammatory skin diseases and examination of individual biomaterials.
Conditions
- Atopic Dermatitis
- Psoriasis
- Lichen Planus
- Alopecia Areata
- Hidradenitis Suppurativa
- Prurigo Nodularis
- Cutaneous Lupus
- Rosacea
Interventions
Topical and systemic drugsDrug
Observational study, treatment decisions are made independently as part of routine clinical care. Recruitment and follow-up will be independent on the type of treatment
Primary outcomes
What the sponsor says the trial is designed to measure.
- Physician-assessed global disease activityTime frame: Baseline, week 2, week 4, every 3 months up to 2 years
- Patient-reported global disease activityTime frame: Baseline, week 2, week 4, every 3 months up to 2 years
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Department of Dermatology and Allergy, University Hospital Schleswig-Holstein
Kiel, Germany · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.